Home
>
US Stocks
>
Athenex Inc
Athenex Inc
ATNX

Athenex Inc (ATNX)

$1.13.77%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$1.07
Today Low/High$1.07 / $1.14
52 Week Low/High$1.03 / $15
P/E ratio-0.75
Market Cap-

Company Details

Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery, development, and commercialization of next generation drugs for the treatment of cancer. Athenex is organized around three platforms, including an Oncology Innovation Platform, a Commercial Platform, and a Global Supply Chain Platform. The Company's current clinical pipeline is derived from four different platform technologies: (1) Orascovery, based on P-glycoprotein inhibitor, (2) Src kinase inhibition, (3) T-cell receptor-engineered T-cells (TCR-T), and (4) Arginine deprivation therapy. Athenex's employees worldwide are dedicated to improving the lives of cancer patients by creating more active and tolerable treatments. Athenex has offices in Buffalo and Clarence, New York; Cranford, New Jersey; Houston, Texas; Chicago, Illinois; Hong Kong; Taipei, Taiwan; multiple locations in Chongqing, China; Manchester, UK; Guatemala City, Guatemala and Buenos Aires, Argentina.
OrganisationAthenex Inc
HeadquatersBuffalo, New York, US
IndustryHealth Technology
CEOJohnson Lau

Discover more

Frequently Asked Questions

What is Athenex Inc (ATNX) share price today?

Can Indians buy Athenex Inc (ATNX) shares?

How can I buy Athenex Inc (ATNX) shares from India?

Can Fractional shares of Athenex Inc (ATNX) be purchased?

What are the documents required to start investing in Athenex Inc (ATNX) stocks?